Tuadles, Reymark .

HRN: 29-08-71  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2026
LEVOFLOXACIN 500MG (TAB)
06/06/2026
06/12/2026
ORAL
500mg
OD
Aplastic Anemia
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines